Literature DB >> 2523952

Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization.

C L Cooper1, C Mueller, T A Sinchaisri, C Pirmez, J Chan, G Kaplan, S M Young, I L Weissman, B R Bloom, T H Rea, R L Modlin.   

Abstract

Analysis of tissue lesions of the major reactional states of leprosy was undertaken to study the immune mechanisms underlying regulation of cell-mediated immunity and delayed-type hypersensitivity (DTH) in man. In situ hybridization hybridization of reversal reaction biopsy specimens for INF-gamma mRNA expression revealed a 10-fold increase in specific mRNA-containing cells over that observed in unresponsive lepromatous patients. Expression of huHF serine esterase, a marker for T cytotoxic cells, were fourfold increased in reversal reaction and tuberculoid lesions above that detected in unresponsive lepromatous individuals. Immunohistology of reversal reactions confirmed a selective increase of Th and T cytotoxic cells in the cellular immune response. Of interest, the microanatomic location of these serine esterase mRNA-containing cells was identical to the distribution of CD4+ cells. Analysis of erythema nodosum leprosum (ENL) lesions revealed differences in the underlying immune processes in comparison with reversal reaction lesions. Although phenotypic Th cells predominated in ENL lesions, IFN-gamma and serine esterase gene expression were markedly reduced. We suggest that reversal reactions represent a hyperimmune DTH response characterized by a selective increase of CD4+ IFN-gamma producing cells and T cytotoxic cells, which result in the clearing of bacilli and concomitant tissue damage. In contrast, ENL reactions may be viewed as a transient diminution of Ts cells and activity leading to a partial and transient augmentation in cell-mediated immunity, perhaps sufficient to result in antibody and immune complex formation, but insufficient to clear bacilli from lesions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523952      PMCID: PMC2189323          DOI: 10.1084/jem.169.5.1565

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Immune complexes and complement hypercatabolism in patients with leprosy.

Authors:  B Bjorvatn; R S Barnetson; G Kronvall; R H Zubler; P H Lambert
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Cell mediated and humoral immunity in "reversal reactions".

Authors:  R S Barnetson; G Bjune; J M Pearson; G Kronvall
Journal:  Int J Lepr Other Mycobact Dis       Date:  1976 Jan-Jun

3.  Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.

Authors:  T Godal; B Myrvang; D R Samuel; W F Ross; M Lofgren
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1973

4.  Histological classification and the immunological spectrum of leprosy.

Authors:  D S Ridley
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

5.  Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon.

Authors:  S N Wemambu; J L Turk; M F Waters; R J Rees
Journal:  Lancet       Date:  1969-11-01       Impact factor: 79.321

6.  Renal manifestations of leprosy: glomerulonephritis, a complication of erythema nodosum leprosum.

Authors:  D J Drutz; R A Gutman
Journal:  Am J Trop Med Hyg       Date:  1973-07       Impact factor: 2.345

7.  Variations in dinitrochlorobenzene responsivity in untreated leprosy: evidence of a beneficial role for anergy.

Authors:  T H Rea; N E Levan
Journal:  Int J Lepr Other Mycobact Dis       Date:  1980-06

8.  Serum and tissue lysozyme in leprosy.

Authors:  T H Rea; C R Taylor
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2.

Authors:  G E Hancock; Z A Cohn; G Kaplan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Defect in the generation of cytotoxic T cells in lepromatous leprosy.

Authors:  J L Stach; M Strobel; F Fumoux; J F Bach
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

View more
  39 in total

Review 1.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Reactions following completion of 1 and 2 year multidrug therapy (MDT).

Authors:  Ma Victoria F Balagon; Robert H Gelber; Rodolfo M Abalos; Roland V Cellona
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis.

Authors:  K A Near; M J Lefford
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy.

Authors:  A D Smith; B Bagheri; R D Streilein; R P Hall
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

5.  Nerve and skin damage in leprosy is associated with increased intralesional heat shock protein.

Authors:  S Khanolkar-Young; D B Young; M J Colston; J N Stanley; D N Lockwood
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  Galectin-3 regulates the innate immune response of human monocytes.

Authors:  Andrew W Chung; Peter A Sieling; Mirjam Schenk; Rosane M B Teles; Stephan R Krutzik; Daniel K Hsu; Fu-Tong Liu; Euzenir N Sarno; Thomas H Rea; Steffen Stenger; Robert L Modlin; Delphine J Lee
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

7.  Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses.

Authors:  Rosane M B Teles; Thomas G Graeber; Stephan R Krutzik; Dennis Montoya; Mirjam Schenk; Delphine J Lee; Evangelia Komisopoulou; Kindra Kelly-Scumpia; Rene Chun; Shankar S Iyer; Euzenir N Sarno; Thomas H Rea; Martin Hewison; John S Adams; Stephen J Popper; David A Relman; Steffen Stenger; Barry R Bloom; Genhong Cheng; Robert L Modlin
Journal:  Science       Date:  2013-02-28       Impact factor: 47.728

8.  Expression of T-cell-associated serine proteinase 1 during murine Leishmania major infection correlates with susceptibility to disease.

Authors:  H Moll; C Müller; R Gillitzer; H Fuchs; M Röllinghoff; M M Simon; M D Kramer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Cytokine production at the site of disease in human tuberculosis.

Authors:  P F Barnes; S Lu; J S Abrams; E Wang; M Yamamura; R L Modlin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 10.  T cell receptor analysis in rheumatoid arthritis: what have we learnt?

Authors:  S H Zwillich; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.